fluconazole

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Tinea Capitis

Conditions

Tinea Capitis

Trial Timeline

Nov 1, 2002 → Mar 1, 2003

NCT ID

NCT00645242

About fluconazole

fluconazole is a phase 3 stage product being developed by Pfizer for Tinea Capitis. The current trial status is completed. This product is registered under clinical trial identifier NCT00645242. Target conditions include Tinea Capitis.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (14)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00002077	Pre-clinical	Completed	—	—	Meningitis, Cryptococcal
NCT00002306	Pre-clinical	Completed	—	—	Meningitis, Cryptococcal
NCT00000627	Pre-clinical	Completed	—	Nov 1, 1994	HIV Infections
NCT00002040	Pre-clinical	Completed	—	—	Meningitis, Cryptococcal
NCT00002010	Pre-clinical	Completed	—	—	Meningitis
NCT00002325	Pre-clinical	Completed	—	—	Mycoses
NCT00000744	Pre-clinical	Completed	—	Dec 1, 1995	Candidiasis
NCT00002339	Phase 3	Completed	—	—	Candidiasis, Esophageal
NCT00002038	Pre-clinical	Completed	—	—	Candidiasis
NCT00002294	Pre-clinical	Completed	—	—	Meningitis, Cryptococcal
NCT00002076	Pre-clinical	Completed	—	—	Meningitis, Cryptococcal
NCT01806623	Phase 3	Completed	Mar 5, 2013	Nov 22, 2013	Vulvovaginal Candidiasis
NCT01680458	Pre-clinical	Completed	Nov 1, 2012	Oct 1, 2014	Deep Mycosis
NCT00645242	Phase 3	Completed	Nov 1, 2002	Mar 1, 2003	Tinea Capitis

Competing Products

20 competing products in Tinea Capitis

See all competitors

Product	Company	Stage	Hype Score
Butenafine Hydrochloride 1% + Butenafine Hydrochloride 1% B + Butenafine Hydrochloride 1% + Vehicle A + Vehicle B	Sun Pharmaceutical	Phase 1	33
Naftifine Hydrochloride Gel 2% + Naftin® Gel 2% + Placebo Topical Gel	Sun Pharmaceutical	Phase 1	33
Naftifine Hydrochloride Cream 2% + Naftin® (Naftifine Hydrochloride) Cream 2% + Placebo Topical Cream	Sun Pharmaceutical	Phase 1	33
Butenafine Hydrochloride Cream, 1% + Lotrimin Ultra® + Butenafine Vehicle	Sun Pharmaceutical	Phase 1	33
Naftifine HCl Cream 1% + Naftin® (Naftifine HCl) Cream 1% + Placebo topical cream	Sun Pharmaceutical	Phase 1	33
Ketoconazole Shampoo, 2% + Ketoconazole Shampoo, 2% (Reference Standard) + Placebo	Sun Pharmaceutical	Phase 1	33
TA103 + Placebo Control	Sun Pharmaceutical	Phase 1	33
Oxiconazole Nitrate Cream 1% + Oxiconazole Nitrate Cream 1% (Oxistat®) + Placebo	Sun Pharmaceutical	Phase 1	33
Butenafine cream 1% manufactured by Taro + Lotrimin Ultra (butenafine) 1% + Butenafine Vehicle manufactured by Taro	Sun Pharmaceutical	Phase 1	33
Sertaconazole nitrate cream 2%	Johnson & Johnson	Phase 3	77
Placebo cream + Ketoconazole 2% cream (formulation F012) (Nizoral) + Ketoconazole 2% cream (formulation F126)	Johnson & Johnson	Phase 3	77
Terbinafine hydrochloride (HCl) + Griseofulvin	Novartis	Phase 3	77
Terbinafine + Terbinafine Placebo	Novartis	Phase 3	77
Terbinafine hydrochloride	Novartis	Phase 3	77
AN2718 + AN2718 + AN2718 + AN2718 + AN2718 + AN2718	Pfizer	Phase 1	32
W0027 + Placebo	GSK plc	Phase 1	32
Bifonazole spray once daily + Bifonazole spray twice daily + Placebo + Placebo + Lamisil Once	Bayer	Phase 2	49
Econazole Nitrate Cream, 1% + Placebo	Viatris	Phase 3	74
LAS41003 + LAS189961 + LAS189962	Almirall	Phase 2	47
Luliconazole Cream 1% + Vehicle Cream	Bausch Health	Approved	80

Other Products from Pfizer